Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.

A study was conducted in an area in north, Italy, on the effluent of two different sized hospitals and the influent and effluent of the receiving municipal treatment plant of one of the examined hospitals. The aim was to investigate 73 selected pharmaceuticals, belonging to twelve different classes, comparing their occurrence in the effluent directly exiting the hospital with that, mixed with the local urban effluent, at the point of its entry and exit from the treatment plant. Consistent differences were found in the concentrations of some antibiotics, analgesics and lipid regulators in the two wastewaters, confirming that hospital effluents should not be considered as possessing the same pollutant nature as urban wastewater. Furthermore, analysis of percentage contributions of the hospital to the treatment plant influent evidences that hospitals represent one of the main sources of pollutants, in particular antibiotics, receptor antagonists and lipid regulators. Hence, an environmental risk assessment, performed on the effluent from the hospital and the influent and effluent from the treatment plant, revealed a high risk for 9 pharmaceuticals in hospital effluent and for 4 of the 9 substances in the treatment plant influent and effluent, with antibiotics being the most critical compounds in terms of contribution and potential environmental risk for the hospital.

[1]  S. Sharma,et al.  Wastewater Reuse and Management , 2013 .

[2]  E. C. Vasconcelos,et al.  Environmental risk assessment of antibiotics: an intensive care unit analysis. , 2009, Chemosphere.

[3]  Isabel Martí,et al.  Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. , 2008, The Science of the total environment.

[4]  Gang Yu,et al.  Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. , 2010, Water research.

[5]  G Keck,et al.  Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. , 2005, Journal of hazardous materials.

[6]  J. Hawkshead Hospital Wastewater Containing Pharmaceutically Active Compounds and Drug-Resistant Organisms: A Source of Environmental Toxicity and Increased Antibiotic Resistance , 2008 .

[7]  Thomas Heberer,et al.  Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents--modeling versus measurements. , 2005, Journal of hazardous materials.

[8]  D. Barceló,et al.  Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. , 2009, Analytical chemistry.

[9]  Walter Giger,et al.  Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. , 2002, Environmental science & technology.

[10]  J. Lazorchak,et al.  Risks to aquatic organisms posed by human pharmaceutical use. , 2008, The Science of the total environment.

[11]  Richard M. Dinsdale,et al.  The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.

[12]  D. Grandjean,et al.  Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. , 2005, Water research.

[13]  A. Pollio,et al.  Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. , 2003, Ecotoxicology and environmental safety.

[14]  P. Verlicchi,et al.  Hospital Wastewaters: Quali-Quantitative Characterization and for Strategies for Their Treatment and Disposal , 2013 .

[15]  J Pinnekamp,et al.  Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. , 2011, Water science and technology : a journal of the International Association on Water Pollution Research.

[16]  Paola Verlicchi,et al.  Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options , 2010 .

[17]  Kurtis Sarafin,et al.  Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. , 2006, The Science of the total environment.

[18]  R M Mader,et al.  Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. , 2007, Chemosphere.

[19]  D. Barceló,et al.  Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. , 2006, Talanta.

[20]  Y. Perrodin,et al.  Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. , 2008, The Science of the total environment.

[21]  Ji-feng Yang,et al.  Occurrence and a screening‐level risk assessment of human pharmaceuticals in the Pearl River system, South China , 2010, Environmental toxicology and chemistry.

[22]  Damià Barceló,et al.  Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.

[23]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[24]  J. Santos,et al.  Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). , 2007, Environment international.

[25]  Francisco Omil,et al.  Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. , 2009, Bioresource technology.

[26]  A. Fernández-Alba,et al.  Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. , 2010, Water research.

[27]  K Kümmerer,et al.  Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review. , 2001, Chemosphere.

[28]  Kevin V Thomas,et al.  Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. , 2009, Environment international.

[29]  D. Barceló,et al.  Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. , 2006, Talanta.

[30]  Despo Fatta-Kassinos,et al.  Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research , 2011, Analytical and bioanalytical chemistry.

[31]  Karin Treyer,et al.  Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. , 2011, Water research.

[32]  Sun-Kyoung Shin,et al.  Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. , 2011, Chemosphere.

[33]  Ignasi Rodríguez-Roda,et al.  Comparison of removal of pharmaceuticals in MBR and activated sludge systems , 2010 .

[34]  T. Ternes,et al.  Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.

[35]  T. Albanis,et al.  Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. , 2010, Journal of hazardous materials.

[36]  Martin Schlabach,et al.  Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. , 2007, Journal of environmental monitoring : JEM.

[37]  M. Reinhard,et al.  Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects. , 2010, The Science of the total environment.

[38]  K. Thomas,et al.  The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. , 2006, The Science of the total environment.

[39]  D. Barceló,et al.  Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. , 2006, Journal of chromatography. A.

[40]  Steve Carter,et al.  Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. , 2010, Water research.